| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |